Worldwide Yearly Screening for Hypospadias
WYSH
Pilot Testing of the Worldwide Yearly Screening for Hypospadias
4 other identifiers
interventional
20
1 country
1
Brief Summary
The purpose of this study is to recruit approximately 20 male participants who have a history of repaired hypospadias to test the feasibility and acceptability of the Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Web Application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2025
CompletedFirst Posted
Study publicly available on registry
May 11, 2025
CompletedStudy Start
First participant enrolled
July 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
March 27, 2026
March 1, 2026
1.3 years
May 2, 2025
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Feasibility: Participant Count to Summarize answers of the Care Planning Tool
The Care Planning Tool within the Worldwide Yearly Screening for Hypospadias (WYSH) Application is a survey containing forty-eight questions regarding possible complications for participating patients (Subsections of penile function, voiding, sexual health, social functioning, psychological health, and doctor-patient communication). These questions will be completed by patients using a five point scale - "Never," "Rarely," "Sometimes," "Often," and "Always" - to populate a Care Plan highlighting areas of concern (with a threshold of two or more metrics above a "Sometimes" response).
Baseline, 3 weeks, 3 months
Acceptability: User Centered Metrics
Participating patients will complete a survey regarding the System Usability to determine ease of functionality throughout the application. This survey contains a scale for participants to graph their response from "Very Difficult" to "Very Easy" following the eleven questions of task completion. Additionally, there is a space provided for open-ended feedback.
Baseline, 3 weeks, 3 months
Acceptability: Cognitive Debriefing Measures
A team from the Wisconsin Surgical Outcomes Research Program (WiSOR) will complete a Cognitive Debriefing Interview with participating patients to assist in determining validation and comprehension. This interview consists of seven open-ended questions regarding participants' thought processes to provide an insight into areas of improvement for the application. Answers will be coded and themes summarized by participant count.
Baseline, 3 weeks, 3 months
Feasibility: System Usability Testing
The Center for User Experience will conduct masked System Usability Testing to provide user-based information on how to improve the online experience for young males and their caregivers and adult males. Usability will be assessed with a level of success rating from "Failure," "Success with a major issue," "Success with a minor issue," and "Complete Success," where minor or major issues and time taken are observed as the participating patient is completing the System Usability Scale.
Baseline, 3 weeks, 3 months
Secondary Outcomes (1)
Provider Acceptability: Usability Scale
Data collected after participating patient completes questionnaire, up to approximately 3 months.
Study Arms (1)
Male Participants with Repaired Hypospadias
EXPERIMENTAL* 3-5 Males, age 5-10 (with parental consent and child assent) * 3-5 Males, age 11-15 (with parental consent and child assent) * 3-5 Males, age 16-20 (with parent consent, child assent until age 18) * 3-5 Males, age 21-65
Interventions
Worldwide Yearly Screening for Hypospadias (WYSH) Web Application
Eligibility Criteria
You may qualify if:
- Males who have a documented history of repaired hypospadias.
- Age groups targeted, based on recommended standards for user experience data from pilot studies:
- Males, age 5-10 (with parental consent and child assent)
- Males, age 11-15 (with parental consent and child assent)
- Males, age 16-20 (with parent consent, child assent until age 18)
- Males, age 21-65
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UW School of Medicine and Public Health
Madison, Wisconsin, 53792, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vinaya Bhatia, MD
UW School of Medicine and Public Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2025
First Posted
May 11, 2025
Study Start
July 23, 2025
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Deidentified individual personal data and supporting information will be made available immediately after publication.
Individual participant data collected during pilot testing, after deidentification, will be accessible in the form of text, tables, publications, figures, etc. to disseminate efficacy of the Care Planning tool within the application.